Dina Randazzo

1.5k total citations · 1 hit paper
55 papers, 955 citations indexed

About

Dina Randazzo is a scholar working on Genetics, Biotechnology and Oncology. According to data from OpenAlex, Dina Randazzo has authored 55 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 14 papers in Biotechnology and 13 papers in Oncology. Recurrent topics in Dina Randazzo's work include Glioma Diagnosis and Treatment (28 papers), Cancer Research and Treatments (14 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Dina Randazzo is often cited by papers focused on Glioma Diagnosis and Treatment (28 papers), Cancer Research and Treatments (14 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Dina Randazzo collaborates with scholars based in United States, Australia and United Kingdom. Dina Randazzo's co-authors include Katherine B. Peters, Annick Desjardins, Henry S. Friedman, James E. Herndon, Frances McSherry, David M. Ashley, John H. Sampson, Gordana Vlahovic, Allan H. Friedman and Darell D. Bigner and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Neurology.

In The Last Decade

Dina Randazzo

50 papers receiving 942 citations

Hit Papers

Recurrent Glioblastoma Treated with Recombinant Poliovirus 2018 2026 2020 2023 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recurrent Glioblastoma Treated with Recombinant Poliovirus
    2018 582 citations Annick Desjardins, Matthias Gromeier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina Randazzo United States 12 432 420 234 224 222 55 955
Patrick M. Reagan United States 19 949 2.2× 130 0.3× 258 1.1× 205 0.9× 366 1.6× 83 1.3k
Daiichiro Hasegawa Japan 18 252 0.6× 113 0.3× 366 1.6× 153 0.7× 233 1.0× 105 1.2k
Cristina Izquierdo Spain 16 158 0.4× 158 0.4× 173 0.7× 137 0.6× 370 1.7× 34 1.0k
Victoria Bedell United States 16 181 0.4× 156 0.4× 431 1.8× 129 0.6× 108 0.5× 40 1.0k
Nuray Akyüz Germany 15 363 0.8× 136 0.3× 328 1.4× 107 0.5× 161 0.7× 53 802
Andreas Ritter Germany 19 173 0.4× 159 0.4× 341 1.5× 90 0.4× 107 0.5× 32 902
Carl Friedrich Classen Germany 17 114 0.3× 120 0.3× 206 0.9× 89 0.4× 121 0.5× 37 617
James Wang United States 14 163 0.4× 107 0.3× 277 1.2× 59 0.3× 95 0.4× 49 903
Shai Rosenberg Israel 13 206 0.5× 142 0.3× 226 1.0× 99 0.4× 37 0.2× 33 731
Giuseppe Stragliotto Sweden 17 204 0.5× 242 0.6× 181 0.8× 38 0.2× 213 1.0× 32 873

Countries citing papers authored by Dina Randazzo

Since Specialization
Citations

This map shows the geographic impact of Dina Randazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Randazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Randazzo more than expected).

Fields of papers citing papers by Dina Randazzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Randazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Randazzo. The network helps show where Dina Randazzo may publish in the future.

Co-authorship network of co-authors of Dina Randazzo

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Randazzo. A scholar is included among the top collaborators of Dina Randazzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Randazzo. Dina Randazzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walsh, Christine M., et al.. (2024). Observational study of HeadPulse sleep bursts in normal subjects. Sleep Medicine. 115. S117–S117. 1 indexed citations
2.
Brown, Michael C., Georgia M. Beasley, Yuanfan Yang, et al.. (2023). Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils. Journal for ImmunoTherapy of Cancer. 11(4). e006463–e006463. 4 indexed citations
3.
Peters, Katherine B., Mary Lou Affronti, Eric Lipp, et al.. (2022). Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial. Supportive Care in Cancer. 30(4). 3463–3471. 4 indexed citations
4.
Kang, Jennifer, Christa B. Swisher, James E. Herndon, et al.. (2021). Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysis. CNS Oncology. 10(3). CNS77–CNS77. 3 indexed citations
5.
Randazzo, Dina, Frances McSherry, James E. Herndon, et al.. (2021). Spiritual well-being and its association with health-related quality of life in primary brain tumor patients. Neuro-Oncology Practice. 8(3). 299–309. 15 indexed citations
6.
Sloan, Andrew E., Robin Buerki, Christopher Murphy, et al.. (2021). LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.. Journal of Clinical Oncology. 39(15_suppl). TPS2065–TPS2065. 11 indexed citations
7.
Kirkpatrick, John P., Frances McSherry, James E. Herndon, et al.. (2021). Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis. Frontiers in Oncology. 11. 631618–631618.
8.
Kirkpatrick, John P., Margaret Johnson, Patrick Healy, et al.. (2020). Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series. Journal of Neuro-Oncology. 147(2). 477–483. 5 indexed citations
9.
Desjardins, Annick, James E. Herndon, Frances McSherry, et al.. (2019). Single‐institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice. Health Science Reports. 2(4). e114–e114. 11 indexed citations
10.
Johnson, Margaret, John P. Kirkpatrick, Annick Desjardins, et al.. (2019). The role of chemotherapy in the treatment of central neurocytoma. CNS Oncology. 8(3). CNS41–CNS41. 12 indexed citations
11.
Randazzo, Dina, Frances McSherry, James E. Herndon, et al.. (2019). Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population. Complementary Therapies in Clinical Practice. 36. 43–48. 8 indexed citations
12.
Dunn‐Pirio, Anastasie, Eric Lipp, James E. Herndon, et al.. (2018). Adjunctive perampanel for glioma-associated epilepsy. Epilepsy & Behavior Case Reports. 10. 114–117. 28 indexed citations
13.
Dunn‐Pirio, Anastasie, Katherine B. Peters, Annick Desjardins, et al.. (2017). Tumor stem cell RNA-loaded dendritic cell vaccine for recurrent glioblastoma: a phase 1 trial (S41.004). Neurology. 88(16_supplement). 4 indexed citations
14.
Miller, C. Ryan, et al.. (2017). Pineal Region Glioblastoma, a Case Report and Literature Review. Frontiers in Oncology. 7. 123–123. 13 indexed citations
15.
Randazzo, Dina, Frances McSherry, James E. Herndon, et al.. (2017). A cross sectional analysis from a single institution’s experience of psychosocial distress and health-related quality of life in the primary brain tumor population. Journal of Neuro-Oncology. 134(2). 363–369. 25 indexed citations
16.
Desjardins, Annick, Dina Randazzo, Katherine B. Peters, et al.. (2017). ACTR-64. PHASE 2 STUDY OF SYM004 FOR ADULT PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM). Neuro-Oncology. 19(suppl_6). vi14–vi14. 1 indexed citations
17.
Randazzo, Dina & Katherine B. Peters. (2016). Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients. CNS Oncology. 5(4). 241–249. 44 indexed citations
18.
Desjardins, Annick, John H. Sampson, Katherine B. Peters, et al.. (2015). Oncolytic polio/rhinovirus recombinant (PVSRIPO) against recurrent glioblastoma (GBM): Optimal dose determination.. Journal of Clinical Oncology. 33(15_suppl). 2068–2068. 5 indexed citations
19.
Ghiaseddin, Ashley, David A. Reardon, Eric Lipp, et al.. (2015). Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.. Journal of Clinical Oncology. 33(15_suppl). 2034–2034. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick M. Reagan Breakdown of academic impact, for papers by Daiichiro Hasegawa Breakdown of academic impact, for papers by Cristina Izquierdo Breakdown of academic impact, for papers by Victoria Bedell Breakdown of academic impact, for papers by Nuray Akyüz Breakdown of academic impact, for papers by Andreas Ritter Breakdown of academic impact, for papers by Carl Friedrich Classen Breakdown of academic impact, for papers by James Wang Breakdown of academic impact, for papers by Shai Rosenberg Breakdown of academic impact, for papers by Giuseppe Stragliotto
Rankless by CCL
2026